HK Stock MarketDetailed Quotes
02563 BIOSTAR PHARM-B
- 29.150
- -0.850-2.83%
Trading Dec 3 10:09 CST
10.63BMarket Cap-59008P/E (TTM)
30.300High28.900Low78.20KVolume30.250Open30.000Pre Close2.31MTurnover0.04%Turnover RatioLossP/E (Static)364.59MShares30.50052wk High14.41P/B6.32BFloat Cap19.48052wk Low--Dividend TTM216.72MShs Float30.500Historical High--Dividend LFY4.67%Amplitude19.480Historical Low29.601Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
BIOSTAR PHARM-B Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|
| Turnover | 103.03%66.64M | 73.71%56.61M | --32.82M | --32.59M |
| Operating income | 103.03%66.64M | 73.71%56.61M | 32.82M | 32.59M |
| Cost of sales | -121.59%-19.81M | -205.85%-18.03M | ---8.94M | ---5.89M |
| Operating expenses | -121.59%-19.81M | -205.85%-18.03M | -8.94M | -5.89M |
| Gross profit | 96.08%46.83M | 44.54%38.58M | 23.88M | 26.69M |
| Selling expenses | 2.57%-95.4M | -19.54%-73.19M | ---97.91M | ---61.22M |
| Administrative expenses | 14.76%-43.9M | 21.97%-29.6M | ---51.5M | ---37.93M |
| Research and development expenses | -52.94%-126.54M | -110.40%-92.67M | ---82.74M | ---44.04M |
| Impairment and provision | 206.03%1.28M | 289.76%1.28M | ---1.21M | ---674K |
| -Other impairment is provision | 206.03%1.28M | 289.76%1.28M | ---1.21M | ---674K |
| Special items of operating profit | -42.62%28.14M | -33.17%25.44M | --49.04M | --38.07M |
| Operating profit | -18.17%-189.59M | -64.51%-130.15M | -160.44M | -79.11M |
| Financing cost | 19.72%-57K | 2.08%-47K | ---71K | ---48K |
| Earning before tax | -18.15%-189.64M | -64.47%-130.19M | -160.51M | -79.16M |
| After-tax profit from continuing operations | -18.15%-189.64M | -64.47%-130.19M | -160.51M | -79.16M |
| Earning after tax | -18.15%-189.64M | -64.47%-130.19M | -160.51M | -79.16M |
| Profit attributable to shareholders | -18.15%-189.64M | -64.47%-130.19M | -160.51M | -79.16M |
| Basic earnings per share | -17.39%-0.54 | -60.87%-0.37 | -0.46 | -0.23 |
| Diluted earnings per share | -17.39%-0.54 | -60.87%-0.37 | -0.46 | -0.23 |
| Currency Unit | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | KPMG | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data